Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation

Toshio Shiotani; Seiichiro Sugimoto; Kota Arakf; Yasuaki Tomioka; Kentaroh Miyoshi; Shinji Otani; Masaomi Yamane; Shinichi Toyooka

Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation

Toshio Shiotani, Seiichiro Sugimoto, Kota Arakf, Yasuaki Tomioka, Kentaroh Miyoshi, Shinji Otani, Masaomi Yamane, Shinichi Toyooka

Research output: Contribution to journal › Article › peer-review

Abstract

Although chronic kidney disease (CKD) commonly develops after lung transplantation (LT), living-donor kidney transplantation (LDKT) for CKD after LT is known to provide favorable outcomes. We describe the longterm follow-up findings of a patient who underwent LDKT after bilateral cadaveric LT. A 37-year-old male underwent LDKT for CKD 18 years after receiving bilateral cadaveric LT. He developed chronic lung allograft dysfunction (CLAD) 20 years after the LT; however, at 26 years after the initial LT, he is still alive with no progression of CLAD or CKD. KT could be a viable option for CKD even after LT in Japan.

Original language	English
Pages (from-to)	87-89
Number of pages	3
Journal	Acta medica Okayama
Volume	75
Issue number	1
Publication status	Published - 2021

Keywords

chronic kidney disease
chronic lung allograft dysfunction
kidney transplantation
lung transplantation
non-tuberculous mycobacterial infection

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{2f4bc074bdf449d4b0031a76ff25f455,

title = "Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation",

abstract = "Although chronic kidney disease (CKD) commonly develops after lung transplantation (LT), living-donor kidney transplantation (LDKT) for CKD after LT is known to provide favorable outcomes. We describe the longterm follow-up findings of a patient who underwent LDKT after bilateral cadaveric LT. A 37-year-old male underwent LDKT for CKD 18 years after receiving bilateral cadaveric LT. He developed chronic lung allograft dysfunction (CLAD) 20 years after the LT; however, at 26 years after the initial LT, he is still alive with no progression of CLAD or CKD. KT could be a viable option for CKD even after LT in Japan.",

keywords = "chronic kidney disease, chronic lung allograft dysfunction, kidney transplantation, lung transplantation, non-tuberculous mycobacterial infection",

author = "Toshio Shiotani and Seiichiro Sugimoto and Kota Arakf and Yasuaki Tomioka and Kentaroh Miyoshi and Shinji Otani and Masaomi Yamane and Shinichi Toyooka",

note = "Funding Information: Acknowledgments.　This case report was supported by a Grant-in-Aid for Scientific Research, Grant No. 20K1774702, from the Japan Society for the Promotion of Science. Publisher Copyright: {\textcopyright} 2021. All Rights Reserved.",

year = "2021",

language = "English",

volume = "75",

pages = "87--89",

journal = "Acta medica Okayama",

issn = "0386-300X",

publisher = "Okayama University",

number = "1",

}

TY - JOUR

T1 - Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation

AU - Shiotani, Toshio

AU - Sugimoto, Seiichiro

AU - Arakf, Kota

AU - Tomioka, Yasuaki

AU - Miyoshi, Kentaroh

AU - Otani, Shinji

AU - Yamane, Masaomi

AU - Toyooka, Shinichi

N1 - Funding Information: Acknowledgments.　This case report was supported by a Grant-in-Aid for Scientific Research, Grant No. 20K1774702, from the Japan Society for the Promotion of Science. Publisher Copyright: © 2021. All Rights Reserved.

PY - 2021

Y1 - 2021

N2 - Although chronic kidney disease (CKD) commonly develops after lung transplantation (LT), living-donor kidney transplantation (LDKT) for CKD after LT is known to provide favorable outcomes. We describe the longterm follow-up findings of a patient who underwent LDKT after bilateral cadaveric LT. A 37-year-old male underwent LDKT for CKD 18 years after receiving bilateral cadaveric LT. He developed chronic lung allograft dysfunction (CLAD) 20 years after the LT; however, at 26 years after the initial LT, he is still alive with no progression of CLAD or CKD. KT could be a viable option for CKD even after LT in Japan.

AB - Although chronic kidney disease (CKD) commonly develops after lung transplantation (LT), living-donor kidney transplantation (LDKT) for CKD after LT is known to provide favorable outcomes. We describe the longterm follow-up findings of a patient who underwent LDKT after bilateral cadaveric LT. A 37-year-old male underwent LDKT for CKD 18 years after receiving bilateral cadaveric LT. He developed chronic lung allograft dysfunction (CLAD) 20 years after the LT; however, at 26 years after the initial LT, he is still alive with no progression of CLAD or CKD. KT could be a viable option for CKD even after LT in Japan.

KW - chronic kidney disease

KW - chronic lung allograft dysfunction

KW - kidney transplantation

KW - lung transplantation

KW - non-tuberculous mycobacterial infection

UR - http://www.scopus.com/inward/record.url?scp=85102225601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102225601&partnerID=8YFLogxK

M3 - Article

C2 - 33649618

AN - SCOPUS:85102225601

SN - 0386-300X

VL - 75

SP - 87

EP - 89

JO - Acta medica Okayama

JF - Acta medica Okayama

IS - 1

ER -

Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this